Early access
Sign in
Taking people in United StatesNo phase

Tests a food navigator program for adults with cancer and food access needs

Tests a patient navigator program aimed at food security and diet in adults with cancer.

Key facts

Who runs it
University of Florida
Where
Gainesville, United StatesSee the site
Trial code
Registry title
The Florida ASCENT Study
Status
Recruiting
People taking part
100 people, planned
Started
5 Dec 2025
Expected to end
Aug 2027
Type of study
Interventional, 2 groupsOne group gets no study treatment, for comparison.
Treatments tested
  • MyCarePulse and ASCENT PN
Record updated
23 July 2026

Who can take part

AI summary

From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.

The trial is looking for adults with a confirmed cancer diagnosis who are not in active cancer treatment, plus health care providers in the partner clinics. It tests a patient navigator and a care tool aimed at food security and diet.

Age
18 to 100 years old.
Sex
All sexes can join.
Disease stage
A cancer diagnosis confirmed by pathology, especially colorectal, prostate, lung, breast, gynecologic, hematologic or skin cancers (including melanoma). The record says the focus is on these types but is not limited to them.
Earlier treatment
People cannot be in active cancer treatment now, such as active chemotherapy, radiation or stem cell transplant. People on stable maintenance therapy, such as endocrine therapy, targeted therapy or some immunotherapy, can join.

Main reasons for not taking part

  • Not living in the state of Florida
  • Currently in active cancer treatment (chemotherapy, radiation, stem cell transplant)
  • No pathologically confirmed cancer diagnosis
  • Cannot read and speak English
  • Cannot give informed consent

The registry criteria, word for word

Show all 17 criteriaShow less

Other criteria

  • Patient Eligibility Inclusion Criteria:
  • ≥18 years old
  • Pathologically confirmed diagnosis, with a focus on, but not limited to, colorectal, prostate, lung, breast, gynecologic, hematologic, or skin (including melanoma) cancers
  • Self-reported ability to read and speak English
  • Able to provide informed consent; Patient Eligibility Exclusion Criteria:
  • ≤18 years old
  • Does not have a pathologically confirmed diagnosis of cancer
  • Currently receiving active cancer treatment (e.g., active chemotherapy, radiation therapy or stem cell transplant); patients on stable maintenance therapy are eligible (e.g., endocrine therapy, targeted therapy, or select immunotherapy)
  • Does not live within the state of Florida. 3) Does not self-reported ability to read and speak English or Spanish. 4) Not able to provide informed consent; Provider Eligibility Inclusion Criteria
  • ≥18 years old
  • Currently works as a physician, physician assistant, patient navigator and/or health system/administrative leader in UF and UM affiliated clinics
  • Self-reported ability to read and speak English or Spanish
  • Able to provide informed consent; Provider Eligibility Exclusion Criteria
  • ≤ 18 years old
  • Does not currently works as a physician, physician assistant, patient navigator and/or health system/administrative leader in UF and UM affiliated clinics
  • Does not self-report having the ability to read and speak English
  • Not able to provide informed consent

Check if you might fit

Answer for yourself. This is not a decision: only the study team can say whether you can take part.

  • Are you between 18 and 100 years old?

Where in United States

  • University of FloridaGainesville, United StatesContact: Dejana Braithwaite, PhD, MScTaking people

About the trial

What the trial wants to find out

The goal of this clinical trial is to adapt, implement, and evaluate MyCarePulse and ASCENT patient navigator to overcome barriers to care among patients with cancer.

Read full original descriptionShow less

The main hypotheses it aims to test are:

* At the patient level, the intervention will result in higher levels of food security, self- efficacy for dietary behaviors, and higher diet quality than standard care. * At the provider level, the intervention will be feasible, acceptable, appropriate, and able to enhance individualized care for patient wellness.

Researchers will compare cancer patients receiving the MyCarePulse and ASCENT patient navigator intervention to those receiving standard care, to see if the intervention improves food security, self-efficacy, and diet quality.

Phase 1

Patient Participants will:

* Complete the ASCENT Questionnaire, which is comprised of the following:

* U.S. Food Security Survey Module (U.S. FSSM) * Patient-Reported Outcomes Measurement Information System (PROMIS-29) * General Self-Efficacy Scale (GSE) * Complete the Automated Self-Administered 24-Hour (ASA24®) Dietary Assessment Tool a total of 4 times. * Be assessed using the Veggie Meter instrument * Participate in two semi-structured interviews

Provider Participants will:

•Participate in one semi-structured interview

Phase 2

Patient Participants will:

* Participate in ASCENT patient navigator screenings and consultations * Complete the ASCENT Questionnaire, which comprises the U.S. FSSM, PROMIS-29, and ASA24®

The 2 groups in the trial

  • Participants receiving Standard care and MyCarePulseNo study treatment, for comparison

    Participants not receiving the ASCENT Patient Navigator intervention, but are still utilizing MyCarePulse for comparison purposes. This arm will be conducted in phase 2 of the study and will have 50 participants (25 per site).

  • Participants receiving ASCENT Patient Navigator (PN) Intervention and MyCarePulseTreatment being tested

    Participants will be receiving the ASCENT Patient Navigator intervention, and the MyCarePulse tool will flag participants who need assistance. They will then be connected to an ASCENT Patient Navigator to get those needs assessed. This arm will be conducted in phase 2 of the study and will have 50 participants (25 per site).

    Treatment: MyCarePulse and ASCENT PN

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.
Official title
The Florida Partnership for Adding Social Context to Address Cancer Survivorship Outcomes (Florida ASCENT)
Plain-language title
Tests a food navigator program for adults with cancer and food access needsGenerated from the registry record. The registry title is the official one.
AI summary
From the trial's eligibility criteria. Read by machine on 12 November 2026.
Fit questions
Built from NCT07042243, who can take part
Record updated
23 July 2026